Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news....

Onyx Pharma (NASDAQ:ONXX) announced positive results from a single-agent Phase 2b study of carfilzomib (a selective, next-generation proteasome inhibitor anti-cancer agent) for relapsed / refractory multiple myeloma (MM) with 24% overall response rate and mediation duration of 7.4 months. ONXX expects to file a New Drug Application (NDA) by year-end 2010 for accelerated approval, in addition to its ongoing pivotal Phase 3 (US) combo ASPIRE study and a pending pivotal Phase 3 (EU) study (FOCUS).

On 7/26/10, Bio-Rad Labs (NYSE:BIO) announced a Premarket Approval application (PMA) submission to FDA, seeking marketing clearance for its fourth-generation HIV assay (GS HIV Combo Ag/Ab EIA or enzyme immunoassay) to aid in the diagnosis of HIV-1 / HIV-2 infection.

Below are summaries of the most recent articles written by Mark Messier at www.BioRunUp.com - please visit the site to read the full articles, in addition to many other free tools and strategies related to binary event investing...

This Week's Watchlist 7/26/10

Arena Pharma (NASDAQ:ARNA) continues its upward momentum, temporarily breaking through $6 on Friday.  How long can it continiue this trend?  Will it keep advancing as it approaches is FDA Panel?  September 16th is a long ways off...  I have no position in ARNA, but remember this stock was $2.89 just a month ago.

www.mikehavRx.com is your prescription for stock index investing updates focused on the healthcare sector, medical innovation, and pending binary events such as FDA decisions and clinical trials. The HavRx Regulatory Catalyst Index update report is currently tracking 613 entries and 424 companies (with approximately 200 stocks trading under $5 per share and 76 private companies). Click here for a subscriber overview article that includes an email archive web link for a 50% discount ($150) promo code off the regular one-year, non-recurring subscription price.

Disclosure: No positions